Table 1 Infliximab attrition rates at different time points
Global continuation rates | Discontinuation rates | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inefficacy | Elective | Safety | ||||||||||
Year | Percentage | 95% CI | Percentage | 95% CI | Percentage | 95% CI | Percentage | 95% CI | ||||
1 | 90.9 | 88.3 | 93.5 | 1.8 | 0.6 | 3.0 | 0.9 | 0.1 | 1.7 | 6.4 | 4.2 | 8.6 |
2 | 80.7 | 77.2 | 84.2 | 6.4 | 4.2 | 8.6 | 1.4 | 0.3 | 2.5 | 11.5 | 8.6 | 14.4 |
3 | 69.6 | 65.5 | 73.7 | 11.2 | 8.4 | 14.0 | 3.4 | 1.8 | 5.0 | 15.8 | 12.5 | 19.1 |
4 | 61.6 | 57.2 | 66.0 | 13.6 | 10.5 | 16.7 | 7.9 | 5.5 | 10.3 | 16.9 | 13.5 | 20.3 |